John Oyler, Chief Executive Officer at BeOne Medicines Ltd. (ONC), sold 3,410 shares at $273.30 ($934K) on 2026-06-23, disclosed to the SEC on 2026-06-25.
Open-market sale of $934k ONC by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $273.30 | 1,800 | $492K | 52.7% |
| 2 | $274.12 | 1,290 | $354K | 37.9% |
| 3 | $275.10 | 320 | $88K | 9.4% |
| Total | $273.78 avg | 3,410 | $934K | 100% |
| Filing → |
| ONC | SELL | 2026-07-17 | $89.4M | — | Filing → |
| ONC | SELL | 2026-07-17 | $20.2M | — | Filing → |
| ONC | SELL | 2026-07-14 | $44.6M | — | Filing → |